The SYNERGY-NASH phase II study demonstrated the efficacy of tirzepatide in resolving metabolic dysfunction-associated steatohepatitis (MASH) and liver fibrosis. The trial conducted by Dr. Rohit Loomba involved 190 participants with biopsy-confirmed MASH and fibrosis. The results indicated a significant resolution of MASH without worsening of fibrosis in patients treated with tirzepatide compared to those in
0 Comments
Former President Donald Trump has recently made claims that the price of insulin was lowered during his administration and not under the leadership of President Joe Biden. Despite acknowledging that the price of insulin is lower under Biden, Trump still wants credit for the policies put in place during his term. These claims are part
0 Comments
Boeing’s Starliner, a human-grade space capsule intended for transporting astronauts to and from the International Space Station, has faced numerous setbacks since its inception in 2014. Despite being awarded a $4.2 billion contract with NASA as part of the Commercial Crew Program, Boeing has struggled to meet its obligations to deliver six missions as promised.
0 Comments
Norway’s $1.7 trillion sovereign wealth fund has announced that it plans to vote against ratifying Tesla CEO Elon Musk’s $56 billion pay package. This decision comes after a Delaware judge invalidated the controversial package earlier this year. As the eighth-largest shareholder in Tesla, the fund’s decision carries significant weight in the upcoming shareholder vote. While
0 Comments
In recent news, a panel of US health experts gathered by the Food and Drug Administration voted against the use of MDMA, also known as ecstasy, for treating post-traumatic stress disorder (PTSD). This decision comes as a blow to California-based Lykos Therapeutics, who had presented two clinical studies that showed promising results in using MDMA
0 Comments